Aberdeen Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-122,960
| Closed | -$3.12M | – | 930 |
|
|
2022
Q3 | $3.12M | Buy |
122,960
+75,600
| +160% | +$1.92M | 0.01% | 630 |
|
|
2022
Q2 | $1.63M | Buy |
47,360
+17,007
| +56% | +$584K | 0.01% | 736 |
|
|
2022
Q1 | $2.21M | Buy |
30,353
+8,631
| +40% | +$628K | 0.01% | 727 |
|
|
2021
Q4 | $2M | Buy |
21,722
+242
| +1% | +$22.2K | ﹤0.01% | 778 |
|
|
2021
Q3 | $2.71M | Buy |
21,480
+7,508
| +54% | +$945K | 0.01% | 742 |
|
|
2021
Q2 | $2.32M | Buy |
13,972
+885
| +7% | +$147K | 0.01% | 741 |
|
|
2021
Q1 | $2.38M | Buy |
13,087
+121
| +0.9% | +$22K | 0.01% | 745 |
|
|
2020
Q4 | $2.59M | Buy |
12,966
+4,870
| +60% | +$974K | 0.01% | 713 |
|
|
2020
Q3 | $1.78M | Buy |
8,096
+4,003
| +98% | +$878K | ﹤0.01% | 724 |
|
|
2020
Q2 | $781K | Buy |
+4,093
| New | +$781K | ﹤0.01% | 814 |
|